Mitra Dipanwita, Sarkar Riya, Ghosh Debidas
Molecular Medicine and Nutrigenomics Research Laboratory, Department of Bio-Medical Laboratory Science and Management, Vidyasagar University, Midnapore 721102, West Bengal, India.
J Complement Integr Med. 2019 Jul 18;16(4):/j/jcim.2019.16.issue-4/jcim-2017-0182/jcim-2017-0182.xml. doi: 10.1515/jcim-2017-0182.
Background Curcuma amada is the most popular traditional medicine in India for the treatment of diabetes. The present study aimed to focus the antidiabetic and antioxidative activity of C. amada through the analysis of biochemical and genomic levels in a dose-dependent manner in streptozotocin-induced male adult rat. Method Streptozotocin-induced diabetic rats were administered orally with hydro-methanolic extract of C. amada at the dose of 10, 20, 40 and 80 mg/100 g body weight of rats for 28 days. The antidiabetic and antioxidative efficacy of the extract on glycemic, enzymatic, genomic and histological sensors along with toxicity study was investigated. Results The result showed a significant antidiabetic and antioxidative effect of the extract at dose-dependent manner. The significant recovery of fasting blood glucose level, serum insulin, activity of carbohydrate metabolic enzymes and antioxidative enzymes in extract-treated diabetic group as compared to untreated diabetic group were noted. After the extract treatment, the size of pancreatic islet and cell population densities were significantly increased. Activities of glutamate oxaloacetate transaminase and glutamate pyruvate transaminase in liver were significantly recovered along with the correction of Bax and Bcl-2 gene expression in hepatic tissue after the extract treatment in diabetic rats in respect to untreated diabetic group. Out of all the doses, the significant effects were noted at the dose of 20 mg/100 g body weight which has been considered as threshold dose in the concern. Conclusion It may be concluded that the significant and corrective effect in most of the sensors was noted at the minimum dose of 20 mg/100 g body weight of hydro-methanolic extract of C. amada without producing any toxicity.
莪术是印度治疗糖尿病最常用的传统药物。本研究旨在通过对链脲佐菌素诱导的成年雄性大鼠进行生化和基因组水平分析,以剂量依赖的方式聚焦莪术的抗糖尿病和抗氧化活性。方法:将链脲佐菌素诱导的糖尿病大鼠以10、20、40和80毫克/100克大鼠体重的剂量口服给予莪术水甲醇提取物,持续28天。研究了该提取物对血糖、酶、基因组和组织学指标的抗糖尿病和抗氧化功效以及毒性。结果:结果显示该提取物具有显著的剂量依赖性抗糖尿病和抗氧化作用。与未治疗的糖尿病组相比,提取物治疗的糖尿病组空腹血糖水平、血清胰岛素、碳水化合物代谢酶和抗氧化酶活性有显著恢复。提取物治疗后,胰岛大小和细胞群体密度显著增加。与未治疗的糖尿病组相比,糖尿病大鼠提取物治疗后肝脏中谷氨酸草酰乙酸转氨酶和谷氨酸丙酮酸转氨酶的活性显著恢复,同时肝组织中Bax和Bcl-2基因表达得到纠正。在所有剂量中,20毫克/100克体重的剂量效果显著,该剂量被视为相关研究中的阈值剂量。结论:可以得出结论,莪术水甲醇提取物最低剂量为20毫克/100克体重时,在大多数指标上具有显著的纠正作用,且未产生任何毒性。